Literature DB >> 25586516

Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement.

A A Artenie1,2, D Jutras-Aswad1,3, É Roy4,5, G Zang1, J-M Bamvita1, A Lévesque1,2, J Bruneau1,2,6.   

Abstract

The role of primary care physicians (PCP) in hepatitis C virus (HCV) prevention is increasingly emphasized. Yet, little is known about the patterns of contacts with PCP among persons who inject drugs (PWID). We sought to assess the 6-month prevalence of PCP visiting among PWID at risk of HCV infection and to explore the associated factors. Baseline data were collected from HCV-seronegative PWID recruited in HEPCO, an observational Hepatitis Cohort study (2004-2011) in Montreal, Canada. An interviewer-administered questionnaire elicited information on socio-demographic factors, drug use patterns and healthcare services utilization. Blood samples were tested for HCV antibodies. Using the Gelberg-Andersen Behavioral Model, hierarchical logistic regression analyses were conducted to identify predisposing, need and enabling factors associated with PCP visiting. Of the 349 participants (mean age = 34; 80.8% male), 32.1% reported visiting a PCP. In the multivariate model, among predisposing factors, male gender [adjusted odds ratio (AOR) = 0.45 (0.25-0.83)], chronic homelessness [AOR = 0.08 (0.01-0.67)], cocaine injection [AOR = 0.46 (0.28-0.76)] and reporting greater illegal or semi-legal income [AOR = 0.48 (0.27-0.85)] were negatively associated with PCP visits. Markers of need were not associated with the outcome. Among enabling factors, contact with street nurses [AOR = 3.86 (1.49-9.90)] and food banks [AOR = 2.01 (1.20-3.37)] was positively associated with PCP visiting. Only one third of participating PWID reported a recent visit to a PCP. While a host of predisposing factors seems to hamper timely contacts with PCP among high-risk PWID, community-based support services may play an important role in initiating dialogue with primary healthcare services in this population.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  drug use; hepatitis C; injection; physician; primary care

Mesh:

Substances:

Year:  2015        PMID: 25586516     DOI: 10.1111/jvh.12393

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  13 in total

1.  Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine.

Authors:  Olena Iakunchykova; Anna Meteliuk; Alexei Zelenev; Alyona Mazhnaya; Melissa Tracy; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2018-04-12

2.  Strategies used by people who inject drugs to avoid stigma in healthcare settings.

Authors:  Dea L Biancarelli; Katie B Biello; Ellen Childs; M Drainoni; Peter Salhaney; Alberto Edeza; Matthew J Mimiaga; Richard Saitz; Angela R Bazzi
Journal:  Drug Alcohol Depend       Date:  2019-03-08       Impact factor: 4.492

3.  Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

Authors:  E Jennifer Edelman; Brent A Moore; Sarah K Calabrese; Gail Berkenblit; Chinazo Cunningham; Viraj Patel; Karran Phillips; Jeanette M Tetrault; Minesh Shah; David A Fiellin; Oni Blackstock
Journal:  AIDS Behav       Date:  2017-04

4.  A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians.

Authors:  Oni J Blackstock; Brent A Moore; Gail V Berkenblit; Sarah K Calabrese; Chinazo O Cunningham; David A Fiellin; Viraj V Patel; Karran A Phillips; Jeanette M Tetrault; Minesh Shah; E Jennifer Edelman
Journal:  J Gen Intern Med       Date:  2016-10-24       Impact factor: 5.128

5.  A community-based study of abscess self-treatment and barriers to medical care among people who inject drugs in the United States.

Authors:  Jenny E Ozga; Jennifer L Syvertsen; John A Zweifler; Robin A Pollini
Journal:  Health Soc Care Community       Date:  2021-09-01

6.  Healthcare coverage and service access for low-income adults with substance use disorders.

Authors:  Mark Olfson; Christine Mauro; Melanie M Wall; C Jean Choi; Colleen L Barry; Ramin Mojtabai
Journal:  J Subst Abuse Treat       Date:  2021-12-29

7.  Acute stressors and clinical characteristics differentiate death by suicide, accident, or natural causes among illicit and prescription opiate users.

Authors:  Alison J Athey; Eleanor E Beale; James C Overholser; Craig A Stockmeier; Courtney L Bagge
Journal:  Drug Alcohol Depend       Date:  2020-01-11       Impact factor: 4.492

8.  HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California.

Authors:  Kimberly Page; Michelle Yu; Jennifer Cohen; Jennifer Evans; Martha Shumway; Elise D Riley
Journal:  BMC Public Health       Date:  2017-02-07       Impact factor: 3.295

9.  Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis.

Authors:  Dan Lewer; Joseph Freer; Emma King; Sarah Larney; Louisa Degenhardt; Emily J Tweed; Vivian D Hope; Magdalena Harris; Tim Millar; Andrew Hayward; Dan Ciccarone; Katherine I Morley
Journal:  Addiction       Date:  2020-02-10       Impact factor: 7.256

10.  "Health Is on the Back Burner:" Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs.

Authors:  Delia Motavalli; Jessica L Taylor; Ellen Childs; Pablo K Valente; Peter Salhaney; Jennifer Olson; Dea L Biancarelli; Alberto Edeza; Joel J Earlywine; Brandon D L Marshall; Mari-Lynn Drainoni; Matthew J Mimiaga; Katie B Biello; Angela R Bazzi
Journal:  J Gen Intern Med       Date:  2020-09-11       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.